Quantum-Si Incorporated - Class A Common Stock (QSI)
1.3300
+0.1600 (13.68%)
NASDAQ · Last Trade: Nov 8th, 11:15 PM EST
News & Press Releases
Quantum-Si (QSI) Q3 2026 Earnings Call Transcriptfool.com
Proteus launch stays on track as costs and cash guidance fall.
Via The Motley Fool · November 6, 2026
Quantum-Si Q3 Earnings Call Highlightsmarketbeat.com
Quantum-Si (NASDAQ:QSI) reported lower third-quarter revenue and narrowed its net loss as it prepared for the planned second-quarter 2027 commercial launch of its Proteus protein sequencing platform.
The company reiterated its full-year revenue guidance of approximately $1 million and lowered its o
Via MarketBeat · November 6, 2026
Quantum-Si (NASDAQ:QSI) Posts Revenue Miss but Narrows Loss as Proteus Transition Loomschartmill.com
Via Chartmill · November 5, 2026
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
Proteus™ remains on track for anticipated Q2 2027 commercial launch
By Quantum-Si Incorporated · Via GlobeNewswire · November 5, 2026
Gaining Ground: FNUC, PRSO, QSI, PDSB Stocks to Watch Now
Wireless production orders, uranium exploration, protein-analysis technology and cancer immunotherapy highlight four Nasdaq-listed companies, with additional sector peers featured inside.
Via AB Newswire · October 28, 2026
Peraso (NASDAQ: PRSO) Soars 54% on $2M 60GHz Wireless Production Order, Volume Tops 225M Shares
DALLAS, TX - October 21, 2026 - Peraso Inc. (NASDAQ: PRSO) surged 54.1% to $0.5914 on trading volume exceeding 225 million shares following the announcement of a production order valued at more than $2 million for its advanced 60GHz fixed wireless access (FWA) technology .
Via AB Newswire · October 21, 2026
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
BRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will provide a business update and report financial results for the third quarter 2026 on Thursday, November 5, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call on the same day at 4:30 PM ET.
By Quantum-Si Incorporated · Via GlobeNewswire · October 16, 2026
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
BRANFORD, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI,” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has received written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market under Listing Rule 5450(a)(1). Nasdaq determined that the closing bid price of the Company’s common stock had been at or above $1.00 per share for at least 10 consecutive business days. Accordingly, Nasdaq has advised the Company that the matter is closed.
By Quantum-Si Incorporated · Via GlobeNewswire · October 15, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · October 9, 2026
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Via Chartmill · October 9, 2026
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
Company is working to deploy 19-amino-acid detection into a developmental sequencing kit and remains confident in demonstrating detection of all 20 amino acids by year-end 2026
By Quantum-Si Incorporated · Via GlobeNewswire · October 8, 2026
These stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · October 6, 2026
Tech Stocks AISP, PRSO, QSI, SCKT: $29M DHS Awards, Military Drones, Protein Sequencing Drive Catalysts
DALLAS, TX - Oct. 1, 2026 - Emerging technology stocks Airship AI Holdings, Inc. (NASDAQ: AISP), Peraso Inc. (NASDAQ: PRSO), Quantum-Si Incorporated (NASDAQ: QSI) and Socket Mobile, Inc. (NASDAQ: SCKT) are in focus following developments across AI, homeland security, military drones, proteomics and enterprise technology .
Via AB Newswire · October 1, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · October 1, 2026
Thursday's session: gap up and gap down stockschartmill.com
Via Chartmill · October 1, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · September 29, 2026
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
All measurable sequencing metrics show profound improvement over Platinum Pro
By Quantum-Si Incorporated · Via GlobeNewswire · September 28, 2026
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Milestone continues the progress towards detection of all 20 amino acids by end of 2026
By Quantum-Si Incorporated · Via GlobeNewswire · September 15, 2026
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
Growing Multi-City Program Continues to Increase Awareness of Proteus and Support Customer Funnel Development Ahead of Commercial Launch
By Quantum-Si Incorporated · Via GlobeNewswire · September 9, 2026
Quantum-Si (QSI) Q2 2026 Earnings Call Transcriptfool.com
Proteus launch delayed to Q2 2027 as company cuts costs and eyes $4B market opportunity.
Via The Motley Fool · August 20, 2026
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that it will be participating in the H.C. Wainwright 28th Annual Global Investment Conference taking place at the Lotte New York Palace Hotel, September 14-16, 2026.
By Quantum-Si Incorporated · Via GlobeNewswire · August 18, 2026
Quantum-Si Q2 Earnings Call Highlightsmarketbeat.com
Quantum-Si (NASDAQ:QSI) said it has moved the planned launch of its Proteus protein sequencing platform to the second quarter of 2027 from the end of 2026, citing the need for an additional integrated instrument design cycle before production. The company also announced a targeted workforce reductio
Via MarketBeat · August 13, 2026
Full Transcript: Quantum-Si Q2 2026 Earnings Callbenzinga.com
Quantum-Si (NASDAQ:QSI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Via Benzinga · August 13, 2026
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencing
By Quantum-Si Incorporated · Via GlobeNewswire · August 13, 2026
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
BRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the second quarter 2026 on Thursday, August 13, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM EDT.
By Quantum-Si Incorporated · Via GlobeNewswire · July 27, 2026